0,909  0,004  Mood disorders treatment
0,908  0,004  Antidepressant
0,904  0,004  Antipsychotic
0,824  0,002  5 Hydroxytryptamine 2C agonist
0,814  0,001  5 Hydroxytryptamine 2B agonist
0,789  0,005  Antiobesity
0,760  0,002  5 Hydroxytryptamine 2 agonist
0,754  0,004  5 Hydroxytryptamine agonist
0,732  0,007  Anxiolytic
0,702  0,007  5 Hydroxytryptamine release stimulant
0,697  0,003  Antismoking
0,689  0,008  Cognition disorders treatment
0,657  0,004  5 Hydroxytryptamine antagonist
0,644  0,002  5 Hydroxytryptamine 2A agonist
0,633  0,003  Alpha 2 adrenoreceptor antagonist
0,609  0,004  Bipolar disorder treatment
0,602  0,003  Alpha 2a adrenoreceptor antagonist
0,584  0,005  Alpha adrenoreceptor antagonist
0,575  0,009  Dependence treatment
0,563  0,004  Acetylcholine antagonist
0,561  0,004  Cholinergic antagonist
0,573  0,023  Antiparkinsonian
0,549  0,005  5 Hydroxytryptamine 2 antagonist
0,528  0,003  Acetylcholine agonist
0,524  0,005  Antimigraine
0,508  0,003  5 Hydroxytryptamine 3 antagonist
0,496  0,005  Dopamine antagonist
0,488  0,005  5 Hydroxytryptamine 2A antagonist
0,519  0,043  Alzheimer's disease treatment
0,479  0,005  Dopamine D2 antagonist
0,512  0,046  Analgesic
0,469  0,004  Dopamine D1 antagonist
0,473  0,019  CYP2D6 inhibitor
0,457  0,004  Alpha 2c adrenoreceptor antagonist
0,473  0,024  Nootropic
0,442  0,005  5 Hydroxytryptamine 2C antagonist
0,425  0,004  Acetylcholine nicotinic antagonist
0,423  0,005  Alpha 2b adrenoreceptor antagonist
0,410  0,003  Dopamine D5 antagonist
0,434  0,037  CYP2D6 substrate
0,402  0,008  Antiadrenergic
0,387  0,006  Acetylcholine M1 receptor antagonist
0,389  0,008  Adrenaline antagonist
0,389  0,010  Cholinergic
0,389  0,014  Sleep disorders treatment
0,434  0,063  Analgesic, non-opioid
0,392  0,023  Anticonvulsant
0,378  0,009  NOS3 expression enhancer
0,380  0,018  5 Hydroxytryptamine uptake stimulant
0,364  0,005  5 Hydroxytryptamine 1F antagonist
0,358  0,004  Neuronal nicotinic receptor antagonist
0,360  0,016  Urinary incontinence treatment
0,370  0,038  Calcium channel activator
0,343  0,012  5 Hydroxytryptamine 2B antagonist
0,340  0,012  5 Hydroxytryptamine 1E antagonist
0,360  0,033  Urologic disorders treatment
0,327  0,004  Acetylcholine M4 receptor antagonist
0,335  0,015  Attention deficit/hyperactivity disorder treatment
0,326  0,009  Alpha 1 adrenoreceptor antagonist
0,349  0,036  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,317  0,004  Dopamine uptake inhibitor
0,318  0,007  Alpha 1b adrenoreceptor antagonist
0,314  0,004  Acetylcholine nicotinic agonist
0,313  0,008  Acetylcholine muscarinic antagonist
0,313  0,008  5 Hydroxytryptamine 1A antagonist
0,320  0,019  Antialcoholic
0,293  0,003  Nicotinic alpha4beta2 receptor antagonist
0,300  0,010  5 Hydroxytryptamine 1 antagonist
0,294  0,004  Acetylcholine muscarinic agonist
0,307  0,017  Antiischemic, cerebral
0,360  0,073  Stroke treatment
0,291  0,005  Alpha adrenoreceptor agonist
0,295  0,009  Alpha 1a adrenoreceptor antagonist
0,340  0,055  Antiepileptic
0,293  0,008  Antiemetic
0,285  0,004  5 Hydroxytryptamine 3A agonist
0,318  0,038  DNA synthesis inhibitor
0,327  0,050  Antineurogenic pain
0,281  0,005  Dopamine agonist
0,293  0,026  Male reproductive disfunction treatment
0,267  0,007  5 Hydroxytryptamine uptake inhibitor
0,297  0,043  Cyclic AMP phosphodiesterase inhibitor
0,288  0,040  Antiparkinsonian, rigidity relieving
0,254  0,007  Alpha 1d adrenoreceptor antagonist
0,259  0,013  Toll-Like receptor antagonist
0,297  0,053  Cardiodepressant
0,257  0,017  Cocaine dependence treatment
0,287  0,052  HERG channel blocker
0,233  0,004  5 Hydroxytryptamine 3A antagonist
0,230  0,004  Alpha 2 adrenoreceptor agonist
0,231  0,004  5 Hydroxytryptamine 5A antagonist
0,230  0,004  Nicotinic neuronal receptor agonist
0,252  0,034  Prostatic (benign) hyperplasia treatment
0,217  0,004  Acetylcholine M1 receptor agonist
0,222  0,011  Obsessive-compulsive disorder treatment
0,216  0,005  Alpha 1 adrenoreceptor agonist
0,241  0,032  Restenosis treatment
0,256  0,047  Sedative
0,214  0,005  Adrenaline uptake inhibitor
0,227  0,018  Autism spectrum disorders treatment
0,274  0,068  Flavin-containing monooxygenase substrate
0,290  0,085  CYP3A4 inhibitor
0,259  0,055  Ca2+/calmodulin-dependent kinase IV inhibitor
0,227  0,023  Uterine stimulant
0,352  0,149  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,206  0,005  5 Hydroxytryptamine 5 antagonist
0,206  0,005  Acetylcholine M5 receptor antagonist
0,206  0,006  Acetylcholine M3 receptor antagonist
0,290  0,094  FMO1 substrate
0,222  0,027  Nav1.2 sodium channel blocker
0,257  0,064  Potassium channel (Voltage-sensitive) blocker
0,236  0,044  Muscle relaxant
0,271  0,082  Spasmolytic
0,190  0,004  Nicotinic receptor alpha4 subunit antagonist
0,251  0,066  Potassium channel blocker
0,258  0,073  Interleukin agonist
0,199  0,014  Antineoplastic alkaloid
0,220  0,039  Irritable Bowel syndrome treatment
0,252  0,072  Cardiovascular analeptic
0,189  0,012  Dopamine D3 antagonist
0,267  0,095  Analeptic
0,176  0,005  Nicotinic receptor alpha7 subunit antagonist
0,264  0,094  Respiratory analeptic
0,177  0,009  Cyclin-dependent kinase 4 inhibitor
0,175  0,008  Acetylcholine M2 receptor antagonist
0,242  0,079  Superoxide dismutase inhibitor
0,274  0,111  Vasodilator, peripheral
0,170  0,010  Acetylcholine M3 receptor agonist
0,173  0,015  5 Hydroxytryptamine 7 antagonist
0,201  0,045  Prostate disorders treatment
0,198  0,043  Antiparkinsonian, tremor relieving
0,167  0,016  Prolactin inhibitor
0,177  0,029  MAP3K9 inhibitor
0,187  0,041  Pulmonary hypertension treatment
0,165  0,020  Protein kinase C mu inhibitor
0,169  0,025  Bronchodilator
0,223  0,079  MAP-kinase-activated kinase 5 inhibitor
0,147  0,004  5 Hydroxytryptamine 3B antagonist
0,228  0,085  Acute neurologic disorders treatment
0,173  0,033  Nav1.6 sodium channel blocker
0,153  0,017  Dopamine D4 antagonist
0,197  0,062  Antiviral (Hepatitis)
0,236  0,101  CYP2C19 substrate
0,142  0,007  5 Hydroxytryptamine 6 antagonist
0,137  0,005  Cyclin-dependent kinase 6 inhibitor
0,258  0,126  CYP3A4 substrate
0,241  0,111  FMO3 substrate
0,279  0,151  Antibacterial
0,193  0,066  VEGF expression inhibitor
0,137  0,012  5 Hydroxytryptamine 1A agonist
0,148  0,027  Opioid antagonist
0,123  0,005  Acetylcholine M2 receptor agonist
0,149  0,033  Chemokine receptor antagonist
0,125  0,009  Acetylcholine M5 receptor agonist
0,175  0,060  Antiviral (Hepatitis C)
0,141  0,026  Toll-Like receptor 4 antagonist
0,122  0,008  Nicotinic receptor alpha3 subunit antagonist
0,219  0,105  Tyrosine 3 hydroxylase inhibitor
0,120  0,007  Protein kinase C beta inhibitor
0,167  0,055  Antinephritic
0,148  0,037  Polo-like kinase-4 inhibitor
0,152  0,044  Adenylate cyclase inhibitor
0,116  0,009  Dopamine transporter inhibitor
0,117  0,011  CDK4/cyclin D1 inhibitor
0,126  0,019  CXC chemokine 4 receptor antagonist
0,189  0,083  5 Hydroxytryptamine 3E antagonist
0,115  0,010  5 Hydroxytryptamine 3 agonist
0,126  0,022  Opioid kappa receptor antagonist
0,159  0,055  Movement disorders treatment
0,109  0,007  Smo receptor antagonist
0,154  0,053  Antifungal (Cryptococcus)
0,148  0,049  Nav1.3 sodium channel blocker
0,110  0,012  CDK4/cyclin D inhibitor
0,122  0,023  Restless leg syndrome treatment
0,213  0,115  Amyotrophic lateral sclerosis treatment
0,101  0,004  Prolactin release inhibitor
0,247  0,153  Antiasthmatic
0,099  0,004  Acetylcholine M4 receptor agonist
0,102  0,010  Nicotinic alpha7 receptor agonist
0,108  0,016  Toll-Like receptor 7 antagonist
0,093  0,005  Dopamine D5 agonist
0,251  0,163  CYP2C9 inhibitor
0,135  0,047  Topoisomerase I inhibitor
0,173  0,085  Systemic lupus erythematosus treatment
0,090  0,003  Nicotinic alpha3beta4 receptor agonist
0,106  0,019  5 Hydroxytryptamine 1 agonist
0,126  0,040  Acetylcholine release stimulant
0,095  0,011  Dopamine D2 agonist
0,111  0,028  Opioid mu receptor antagonist
0,085  0,004  Alpha 1L adrenoreceptor agonist
0,084  0,004  Phenylethanolamine N methyltransferase inhibitor
0,083  0,003  Nicotinic alpha4 receptor agonist
0,087  0,007  Nicotinic receptor beta4 subunit antagonist
0,231  0,153  Vasodilator, coronary
0,088  0,010  Nicotinic alpha3beta2 receptor antagonist
0,123  0,048  GABA C receptor agonist
0,118  0,044  Antihistaminic
0,128  0,053  Antiprotozoal (Babesia)
0,082  0,007  Nociceptin (N/OFQ) receptor antagonist
0,087  0,012  CC chemokine 3 receptor antagonist
0,104  0,031  Antiprotozoal activity enhancer
0,108  0,036  Alpha 2d adrenoreceptor antagonist
0,113  0,043  Nitric-oxide synthase inhibitor
0,143  0,073  Activin receptor-like kinase 2 inhibitor
0,075  0,005  p53 inhibitor
0,217  0,148  Antiallergic
0,177  0,108  Antiviral (Ebola)
0,167  0,097  Anesthetic general
0,085  0,016  Antihemophilic
0,110  0,043  Histamine antagonist
0,168  0,101  Psychostimulant
0,094  0,026  5 Hydroxytryptamine 1B antagonist
0,150  0,085  Sigma receptor agonist
0,075  0,010  Alpha 1L adrenoreceptor antagonist
0,142  0,081  Antidiarrheal
0,204  0,143  Gastrin inhibitor
0,091  0,030  Cushing's syndrome treatment
0,116  0,056  Mental retardation treatment
0,086  0,026  Phospholipase D inhibitor
0,084  0,028  Female sexual dysfunction treatment
0,076  0,020  Toll-Like receptor 8 antagonist
0,217  0,161  Interleukin 2 agonist
0,059  0,004  Nicotinic alpha4beta2 receptor agonist
0,072  0,017  Dipeptidyl peptidase inhibitor
0,083  0,029  5 Hydroxytryptamine 1D antagonist
0,075  0,022  Sigma receptor antagonist
0,086  0,032  MAP kinase kinase 7 inhibitor
0,088  0,036  Narcotic antagonist
0,135  0,083  Skeletal muscle relaxant
0,137  0,087  Adenylate cyclase stimulant
0,064  0,015  Cyclin D3 inhibitor
0,072  0,024  CC chemokine 2 receptor antagonist
0,163  0,115  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,144  0,097  Hearing loss treatment
0,120  0,074  Cyclin-dependent kinase inhibitor
0,063  0,017  Histamine H4 receptor antagonist
0,068  0,024  Cyclin A1 inhibitor
0,086  0,043  Sleep apnea treatment
0,075  0,032  Uterine relaxant
0,124  0,082  Toll-Like receptor 9 antagonist
0,096  0,055  SULT1E1 substrate
0,091  0,052  Tocolytic
0,203  0,163  Antineoplastic (brain cancer)
0,232  0,192  CYP2C19 inhibitor
0,061  0,023  5 Hydroxytryptamine 4 antagonist
0,045  0,008  Protein kinase C beta II inhibitor
0,178  0,141  Antihypotensive
0,093  0,057  Paget's disease treatment
0,217  0,182  Toll-Like receptor agonist
0,217  0,181  Toll-Like receptor 7 agonist
0,039  0,004  Antibiotic Quinolone-like
0,044  0,010  Dipeptidyl peptidase I inhibitor
0,083  0,049  CC chemokine receptor antagonist
0,041  0,007  Nociceptin (N/OFQ) receptor agonist
0,065  0,031  Phosphodiesterase 1A inhibitor
0,066  0,034  Androgen agonist
0,049  0,017  Alpha 1d adrenoreceptor agonist
0,130  0,099  Pregnane X receptor agonist
0,062  0,031  Bombesin 3 receptor antagonist
0,054  0,026  Alpha 1b adrenoreceptor agonist
0,055  0,027  Glycine transporter inhibitor
0,046  0,018  Vascular adhesion protein 1 inhibitor
0,041  0,013  CDK6/cyclin D3 inhibitor
0,079  0,052  Antidote, organophosphates
0,071  0,045  Premenstrual syndrome treatment
0,083  0,057  Inducible nitric-oxide synthase inhibitor
0,107  0,081  Menstruation disorders treatment
0,081  0,056  Glycine receptor antagonist
0,144  0,120  Phospholipase C inhibitor
0,124  0,100  Diuretic
0,035  0,011  5 Hydroxytryptamine 6 agonist
0,033  0,009  Follicle-stimulating hormone agonist
0,048  0,026  Poly(ADP-ribose) polymerase inhibitor
0,042  0,019  Glycine transporter 1 inhibitor
0,047  0,025  Dipeptidyl peptidase IV inhibitor
0,053  0,032  Dopamine D4 agonist
0,032  0,010  Alpha 1a adrenoreceptor agonist
0,206  0,184  GST M1-1 substrate
0,030  0,009  Dopamine D1 agonist
0,081  0,061  MAP-kinase-activated kinase inhibitor
0,260  0,241  Caspase 9 stimulant
0,070  0,051  Prokinetic
0,040  0,022  Somatostatin 4 agonist
0,043  0,026  Neurokinin 1 antagonist
0,060  0,043  Cyclin D1 inhibitor
0,025  0,009  Vesicular acetylcholine transporter inhibitor
0,039  0,024  Poly(ADP-ribose) polymerase 1 inhibitor
0,047  0,032  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,019  0,004  Cyclin D2 inhibitor
0,193  0,178  Antihypertensive
0,024  0,010  5-Alpha-reductase 1 inhibitor
0,030  0,015  Antibiotic Naphthyridine-like
0,126  0,113  Neuropathy treatment
0,069  0,056  Glycine receptor agonist
0,058  0,046  Potassium channel (Ca-activated) blocker
0,038  0,026  5-Alpha-reductase inhibitor
0,030  0,019  Cyclin E2 inhibitor
0,052  0,041  Protein kinase C eta inhibitor
0,146  0,136  Antirickettsial
0,058  0,048  Narcolepsy treatment
0,047  0,038  Neurokinin antagonist
0,095  0,087  Protein kinase C gamma inhibitor
0,066  0,058  Dysmenorrhea treatment
0,028  0,020  HCV NS5A inhibitor
0,017  0,009  NMDA receptor phencyclidine site antagonist
0,043  0,036  Glutamate (mGluR5) agonist
0,077  0,071  Histamine H2 receptor antagonist
0,061  0,055  Cyclin B3 inhibitor
0,079  0,072  mTOR complex 2 inhibitor
0,043  0,037  Parathyroid hormone antagonist
0,040  0,034  Histamine H3 receptor antagonist
0,058  0,054  Phosphodiesterase 1C inhibitor
0,074  0,070  Insulin like growth factor 1 antagonist
0,051  0,046  Peristaltic stimulant
0,046  0,042  NMDA 2A receptor antagonist
0,043  0,039  Glutamate (mGluR group I) agonist
0,056  0,053  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,076  0,073  Insulin growth factor antagonist
0,018  0,015  5-Alpha-reductase 2 inhibitor
0,070  0,068  Histamine H1 receptor antagonist
0,028  0,026  Endothelial nitric-oxide synthase inhibitor
0,077  0,076  CC chemokine 5 receptor agonist
0,104  0,103  Tyrosine-protein kinase receptor antagonist

